drugset / Trial / NCT00923533

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

NCT00923533

Phase 1 Completed 34 enrolled Boryung Pharmaceutical Co., Ltd
Non-randomizedCrossoverOpen-label

Summary

To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.

Timeline

Start
2009-03
Primary completion
2009-05
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fimasartan Small molecule 240 mg Oral
Comparator Hydrochlorothiazide Unknown 25 mg Oral